581 related articles for article (PubMed ID: 22814620)
1. TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation.
Jouan-Lanhouet S; Arshad MI; Piquet-Pellorce C; Martin-Chouly C; Le Moigne-Muller G; Van Herreweghe F; Takahashi N; Sergent O; Lagadic-Gossmann D; Vandenabeele P; Samson M; Dimanche-Boitrel MT
Cell Death Differ; 2012 Dec; 19(12):2003-14. PubMed ID: 22814620
[TBL] [Abstract][Full Text] [Related]
2. Sibiriline, a new small chemical inhibitor of receptor-interacting protein kinase 1, prevents immune-dependent hepatitis.
Le Cann F; Delehouzé C; Leverrier-Penna S; Filliol A; Comte A; Delalande O; Desban N; Baratte B; Gallais I; Piquet-Pellorce C; Faurez F; Bonnet M; Mettey Y; Goekjian P; Samson M; Vandenabeele P; Bach S; Dimanche-Boitrel MT
FEBS J; 2017 Sep; 284(18):3050-3068. PubMed ID: 28715128
[TBL] [Abstract][Full Text] [Related]
3. TNF-induced necroptosis and PARP-1-mediated necrosis represent distinct routes to programmed necrotic cell death.
Sosna J; Voigt S; Mathieu S; Lange A; Thon L; Davarnia P; Herdegen T; Linkermann A; Rittger A; Chan FK; Kabelitz D; Schütze S; Adam D
Cell Mol Life Sci; 2014 Jan; 71(2):331-48. PubMed ID: 23760205
[TBL] [Abstract][Full Text] [Related]
4. RIPK1 can function as an inhibitor rather than an initiator of RIPK3-dependent necroptosis.
Kearney CJ; Cullen SP; Clancy D; Martin SJ
FEBS J; 2014 Nov; 281(21):4921-34. PubMed ID: 25195660
[TBL] [Abstract][Full Text] [Related]
5. RIPK1 both positively and negatively regulates RIPK3 oligomerization and necroptosis.
Orozco S; Yatim N; Werner MR; Tran H; Gunja SY; Tait SW; Albert ML; Green DR; Oberst A
Cell Death Differ; 2014 Oct; 21(10):1511-21. PubMed ID: 24902904
[TBL] [Abstract][Full Text] [Related]
6. Critical contribution of oxidative stress to TNFα-induced necroptosis downstream of RIPK1 activation.
Shindo R; Kakehashi H; Okumura K; Kumagai Y; Nakano H
Biochem Biophys Res Commun; 2013 Jun; 436(2):212-6. PubMed ID: 23727581
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of RIPK1 Markedly Exacerbates Murine Immune-Mediated Liver Injury through Massive Apoptosis of Hepatocytes, Independent of Necroptosis and Inhibition of NF-κB.
Suda J; Dara L; Yang L; Aghajan M; Song Y; Kaplowitz N; Liu ZX
J Immunol; 2016 Oct; 197(8):3120-3129. PubMed ID: 27605011
[TBL] [Abstract][Full Text] [Related]
8. RIPK1/RIPK3/MLKL-mediated necroptosis contributes to compression-induced rat nucleus pulposus cells death.
Chen S; Lv X; Hu B; Shao Z; Wang B; Ma K; Lin H; Cui M
Apoptosis; 2017 May; 22(5):626-638. PubMed ID: 28289909
[TBL] [Abstract][Full Text] [Related]
9. Differential roles of RIPK1 and RIPK3 in TNF-induced necroptosis and chemotherapeutic agent-induced cell death.
Moriwaki K; Bertin J; Gough PJ; Orlowski GM; Chan FK
Cell Death Dis; 2015 Feb; 6(2):e1636. PubMed ID: 25675296
[TBL] [Abstract][Full Text] [Related]
10. Protein-Bound Polysaccharides from
Pawlikowska M; Jędrzejewski T; Brożyna AA; Wrotek S
Cell Physiol Biochem; 2020 Jun; 54(4):591-604. PubMed ID: 32531147
[TBL] [Abstract][Full Text] [Related]
11. The chemical inhibitors of cellular death, PJ34 and Necrostatin-1, down-regulate IL-33 expression in liver.
Arshad MI; Piquet-Pellorce C; Filliol A; L'Helgoualc'h A; Lucas-Clerc C; Jouan-Lanhouet S; Dimanche-Boitrel MT; Samson M
J Mol Med (Berl); 2015 Aug; 93(8):867-78. PubMed ID: 25747661
[TBL] [Abstract][Full Text] [Related]
12. RIPK3 contributes to TNFR1-mediated RIPK1 kinase-dependent apoptosis in conditions of cIAP1/2 depletion or TAK1 kinase inhibition.
Dondelinger Y; Aguileta MA; Goossens V; Dubuisson C; Grootjans S; Dejardin E; Vandenabeele P; Bertrand MJ
Cell Death Differ; 2013 Oct; 20(10):1381-92. PubMed ID: 23892367
[TBL] [Abstract][Full Text] [Related]
13. ROS-Mediated Necroptosis Is Involved in Iron Overload-Induced Osteoblastic Cell Death.
Tian Q; Qin B; Gu Y; Zhou L; Chen S; Zhang S; Zhang S; Han Q; Liu Y; Wu X
Oxid Med Cell Longev; 2020; 2020():1295382. PubMed ID: 33123307
[TBL] [Abstract][Full Text] [Related]
14. Curcumol induces RIPK1/RIPK3 complex-dependent necroptosis via JNK1/2-ROS signaling in hepatic stellate cells.
Jia Y; Wang F; Guo Q; Li M; Wang L; Zhang Z; Jiang S; Jin H; Chen A; Tan S; Zhang F; Shao J; Zheng S
Redox Biol; 2018 Oct; 19():375-387. PubMed ID: 30237126
[TBL] [Abstract][Full Text] [Related]
15. The role of PARP activation in glutamate-induced necroptosis in HT-22 cells.
Xu X; Chua CC; Zhang M; Geng D; Liu CF; Hamdy RC; Chua BH
Brain Res; 2010 Jul; 1343():206-12. PubMed ID: 20451505
[TBL] [Abstract][Full Text] [Related]
16. High glucose-induced apoptosis and necroptosis in podocytes is regulated by UCHL1 via RIPK1/RIPK3 pathway.
Xu Y; Gao H; Hu Y; Fang Y; Qi C; Huang J; Cai X; Wu H; Ding X; Zhang Z
Exp Cell Res; 2019 Sep; 382(2):111463. PubMed ID: 31247189
[TBL] [Abstract][Full Text] [Related]
17. A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis.
Fauster A; Rebsamen M; Huber KV; Bigenzahn JW; Stukalov A; Lardeau CH; Scorzoni S; Bruckner M; Gridling M; Parapatics K; Colinge J; Bennett KL; Kubicek S; Krautwald S; Linkermann A; Superti-Furga G
Cell Death Dis; 2015 May; 6(5):e1767. PubMed ID: 25996294
[TBL] [Abstract][Full Text] [Related]
18. The Roles of ROS and Caspases in TRAIL-Induced Apoptosis and Necroptosis in Human Pancreatic Cancer Cells.
Zhang M; Harashima N; Moritani T; Huang W; Harada M
PLoS One; 2015; 10(5):e0127386. PubMed ID: 26000607
[TBL] [Abstract][Full Text] [Related]
19. RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury.
Newton K; Dugger DL; Maltzman A; Greve JM; Hedehus M; Martin-McNulty B; Carano RA; Cao TC; van Bruggen N; Bernstein L; Lee WP; Wu X; DeVoss J; Zhang J; Jeet S; Peng I; McKenzie BS; Roose-Girma M; Caplazi P; Diehl L; Webster JD; Vucic D
Cell Death Differ; 2016 Sep; 23(9):1565-76. PubMed ID: 27177019
[TBL] [Abstract][Full Text] [Related]
20. RIPK1 Mediates TNF-Induced Intestinal Crypt Apoptosis During Chronic NF-κB Activation.
Wong J; Garcia-Carbonell R; Zelic M; Ho SB; Boland BS; Yao SJ; Desai SA; Das S; Planell N; Harris PA; Font-Burgada J; Taniguchi K; Bertin J; Salas A; Pasparakis M; Gough PJ; Kelliher M; Karin M; Guma M
Cell Mol Gastroenterol Hepatol; 2020; 9(2):295-312. PubMed ID: 31606566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
